Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses

Neuropharmacology

Volumn 41, Issue 3, 2001, Pages 351-359

  Zapata, Agustin ^a   Witkin, Jeffrey M ^a   Shippenberg, Toni S ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

(+) PD 128907; D3 receptor; Dopamine; Knock out mice; No net flux microdialysis; Ventral striatum

Indexed keywords

3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; COCAINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR D3; POTASSIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINE BLOOD LEVEL; DOPAMINE UPTAKE; FRACTIONATION; GENOTYPE; KNOCKOUT MOUSE; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE;

ANIMALS; BENZOPYRANS; BRAIN; COCAINE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; KINETICS; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; OXAZINES; POTASSIUM; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0034888427     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(01)00069-7     Document Type: Article

References (36)

1. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
2. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors
3. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
4. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice
5. Combined use of mutant mice and classical pharmacology to characterise receptor functions: The case of dopamine D2 and D3 receptors
6. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum
7. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis
8. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype?
9. Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo
10. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways
11. Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum
12. Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors
13. Quantitative microdialysis of neurotransmitters
14. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations
15. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice
16. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities
17. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography
18. Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo
19. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin
20. Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors
21. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain
22. Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbus using microdialysis
23. Role of dopamine D3 receptors in thermoregulation: A reappraisal
24. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907
25. A functional test identifies dopamine agonists selective for D3 versus D2 receptors
26. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents
27. The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine
28. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
29. The third dopamine receptor (D3) as a novel target for antipsychotics
30. D3 dopamine receptor-deficient mouse: Evidence for reduced anxiety
31. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors
32. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: Evidence for a role of D3 receptors?
33. Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour
34. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists
35. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors